Domainex Ltd wins biotechnology innovation award

22-Aug-2007

Domainex Ltd, won the Innovation in Enabling biotechnology Award at the 2007 UK BioEntrepreneurial Company of the Year Awards, presented by UK Trade & Investment in London 4th. More than 180 industry leaders attended the annual ceremony, which recognises innovation and entrepreneurship in the biotechnology industry.

Domainex

Dr Renos Savva (right) receives the award from Andrew Cahn (left)

Dr Renos Savva, one of the company's founders and the CEO of Domainex, Dr Eddy Littler, received the award from Mr Andrew Cahn, CEO of UK Trade & Investment. "We are delighted to have been presented with this award, which recognises our commitment to developing new technologies for streamlining and accelerating the drug discovery process," said Dr Savva.

Domainex Ltd has developed a unique high-throughput technology for producing soluble and stable protein fragments that are suitable for compound screening, structural biology studies or antibody production. The approach resolves the discovery 'gap' that exists between the vast amount of genomic information that is now available, and the accessibility of the corresponding proteins for use in target validation and drug discovery.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances